© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#blood cancer

Yescarta, CAR-T, axicabtagene ciloleucel
CAR-T Therapy: Lifeline to A Cure?
Imbruvica Bests Chemotherapy for Older People With Leukemia
Blood Cancers 101
David Tracy received an experimental drug for BPDCN, a rare blood cancer, which is now part of standard therapy for the disease. The initial lesions on his back and chest are mostly gone or fading.

Researchers Making Headway on Treatment for Rare Blood Cancer

The trial is testing an experimental drug that targets one of the malignant immune cells that are a hallmark of the disease.
T cells attacking cancer cell

CAR T Cells Survive by Going Undercover

The researchers are now designing a first-in-human clinical trial to test the effectiveness of this approach in patients.

Cancer Awareness Months and Days

Shingles More Likely to Develop in People With Cancer

But new vaccines hold promise for prevention.
Damian Green, MD, presented the first results from his trial of genetically engineered immune cells for multiple myeloma. Green says this type of treatment could “dramatically alter the landscape in terms of how we manage multiple myeloma.”

‘Exciting’ but Early Results in Trial of Immunotherapy for Myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.

Study Aims to Cure Blood Cancers With Transplants That Could Block HIV, Too

Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Connor McMahon (center), a 17-year-old three-time survivor of acute lymphblastic leukemia, on the “Good Morning America” set with co-host Michael Strahan (left) and New York Rangers goalie Henrik Lundqvist (right), McMahon’s favorite hockey player

Three-Time Cancer Survivor Is Helping Kids Like Him

After his first bout with acute lymphoblastic leukemia, Connor McMahon wanted to give other children hope.
Mohamed Sorror, MD

Improving Quality of Life and Survival in Older Bone Marrow Transplant Patients

The large clinical trial is funded by a $3.5M federal research grant.
Red and white blood cells

French Company Receives Funding to Develop Adult Leukemia Vaccine

INVAC-1 vaccine targets the telomerase enzyme involved in cancer cell growth.

Blood Cancer Awareness Month

September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
Multiple myeloma cells

Study May Lead to New Approaches to Treating Early, Smoldering Myeloma

The findings lay the groundwork for tests that can identify whether the disease is likely to progress rapidly.
At Wilford Hall Medical Center, staff registered nurse Roland Bautista (center) and Maj. (Dr.) Dustin Stevenson, medical director for bone marrow transplants, prepare to give Christine Jackson (left) a stem cell transplant from a matching unrelated donor.

Success With ‘Half-Matched’ Donors Leads Transplant Advances

The haploidentical transplant process has vastly expanded the pool of bone marrow or stem cell donors.

3 New Projects Map Out Immune Responses to Cancers

Scientists aim to gather knowledge that improves future immunotherapies.

Staggering Prices Slow Insurers’ Coverage of CAR-T Cancer Therapy

The approved therapies have roiled the insurance approval process, which has led to delays and denials of coverage.
Red and white blood cells

Rare Blood Cancer Patient Is Cancer-Free After Clinical Trial

Keith Rohleder participated in a clinical trial—which included chemotherapy and radiation—and then received a stem cell transplant.
Multiple myeloma cells

What Is Multiple Myeloma?

Outcomes are improving for this hard-to-treat blood cancer.
Advertisement
Treatment News
Features